Associated Papers
CYP2C:TG Haplotype in Native Mexicans, Molecular Ancestry and Its Implications for CYP2C19 Genotype-Phenotype Correlation.
de la Cruz CG et al.
Pharmaceuticals (basel, Switzerland), 2025
Clinical significance and gene prediction of a novel classification system based on tacrolimus concentration-to-dose ratio in the early post-liver transplant period.
Fan J et al.
Frontiers in Pharmacology, 2025
40761401 (PubMed )
Supplement: Supplementaryfile2.xlsx › AllPatients
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?
Ganoci L et al.
Genes, 2024
Influence of novel CYP2C-haplotype on proton pump inhibitor pharmacokinetics in children.
Kyler KE et al.
Clinical and Translational Science, 2024
Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.
Zhang T et al.
Peerj, 2024
39465171 (PubMed )
Supplement: peerj-12-18360-s002.7z › drug-metabolizing_enzymes_and_transporter__DMET__microarray › markerlist.xlsx › markerlist.TXT
Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro Activity.
Zubiaur P et al.
Clinical Pharmacology and Therapeutics, 2023
Korean, Japanese, and Chinese populations featured similar genes encoding drug-metabolizing enzymes and transporters: a DMET Plus microarray assessment.
Yi S et al.
Pharmacogenetics and Genomics, 2014
Select a paper to view details